JNJ vs. JPM: Johnson & Johnson vs. JPMorgan Chase Stock Comparison

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas JPMorgan Chase (JPM) belongs to Financials (Banks) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Johnson & Johnson (JNJ) at 20.02% and JPMorgan Chase (JPM) at 18.01% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

Johnson & Johnson (JNJ) at 16.20% retains a top-quartile share of revenue as profit, ahead of JPMorgan Chase (JPM) at 34.59%, which keeps about the industry-typical share.

Johnson & Johnson (JNJ) reports operating margin of 25.74%; JPMorgan Chase (JPM) doesn’t report a comparable line — in Banks, funding costs sit inside the core business rather than below an operating line, so profitability is better judged on net margin or ROE.

Profitability Metrics

Growth

Both Johnson & Johnson (JNJ) at 6.05% and JPMorgan Chase (JPM) at 7.32% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while JPMorgan Chase (JPM) at 1.37% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Johnson & Johnson (JNJ) shows current ratio of 1.02; JPMorgan Chase (JPM) doesn’t get one — Banks balance sheets aren’t split into current and non-current buckets, so short-term liquidity there is judged through regulatory measures instead.

Johnson & Johnson (JNJ) shows debt-to-equity ratio of 0.55; for JPMorgan Chase (JPM) the ratio is set aside — in Banks, balance-sheet leverage is part of the business model itself, so capital-adequacy measures do the job this ratio does elsewhere.

Financial Strength Metrics

Dividends

JPMorgan Chase (JPM) at 1.82% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

JPMorgan Chase (JPM) at 25.80% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.

Dividend Metrics

Valuation

Johnson & Johnson (JNJ) at 41.92 is near its industry’s usual P/E ratio, while JPMorgan Chase (JPM) at 14.03 sits in the richer quartile — JPM needs stronger growth or earnings quality to justify the premium.

Johnson & Johnson (JNJ) shows P/S ratio of 6.69; for JPMorgan Chase (JPM) the multiple is skipped — in Banks, income is dominated by interest spread rather than a conventional revenue line, so pricing per dollar of sales loses meaning and book- or earnings-based multiples carry the comparison.

Both look rich against book: Johnson & Johnson (JNJ) at 8.16 sits in the upper P/B ratio quartile, and JPMorgan Chase (JPM) at 2.53 prices even higher, above its industry range.

Valuation Metrics